Stockscreener 앱 받기
8.96
2.17%
0.19
시간 외 거래:
8.85
-0.11
-1.23%
Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스
Biotech Co. Emergent Gives Interim GC Permanent Role - Law360
Emergent BioSolutions appoints new chief medical officer - Investing.com
Emergent BioSolutions (EBS) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
Emergent Bio's smallpox vaccine gets US approval for mpox - AOL
Assenagon Asset Management S.A. Increases Stock Position in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat
Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way? - Simply Wall St
Zacks.com featured highlights include American Airlines, Air Canada, EmergentBioSolutions, Berry and Cracker Barrel Old Country Store - Yahoo Finance
5 Broker Liked Stocks to Keep an Eye on After Recent Analyst Upgrades - Yahoo Finance
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Emergent BioSolutions Inc. Common Stock - GlobeNewswire Inc.
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 - The Manila Times
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference - The Bakersfield Californian
Emergent BioSolutions (NYSE:EBS) Shares Up 3.2%Here's What Happened - MarketBeat
Biopharma Layoffs Roundup - Contract Pharma
Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata - Yahoo Finance
3 Stocks Poised for Better Returns With New Analyst Coverage - Yahoo Finance
Emergent BioSolutions Inc. (NYSE:EBS) Short Interest Up 84.1% in September - MarketBeat
Emergent BioSolutions Inc. (NYSE:EBS) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 - Insider Monkey
Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - GuruFocus.com
Smallpox Treatment Market to Experience Holistic Expansion - openPR
Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says - Yahoo Finance
Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic - The Manila Times
Emergent BioSolutions Inc. (NYSE:EBS) Shares Sold by AQR Capital Management LLC - MarketBeat
12 Best Performing Cheap Stocks in 2024 - Insider Monkey
Lipid Nanoparticles Market Research 2024 - GlobeNewswire Inc.
Emergent BioSolutions (STU:ER4) EV-to-EBITDA : -3.33 (As of Oct. 06, 2024) - GuruFocus.com
Emergent BioSolutions (STU:ER4) Profitability Rank : 7 (As of Jun. 2024) - GuruFocus.com
Emergent BioSolutions (STU:ER4) Free Cash Flow per Share : €0.69 (TTM As of Jun. 2024) - GuruFocus.com
Renaissance Technologies LLC Trims Position in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat
Squarepoint Ops LLC Buys Shares of 231,014 Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat
Emergent BioSolutions grants CFO equity award By Investing.com - Investing.com Australia
Emergent BioSolutions grants CFO equity award - Investing.com India
Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario - citybiz
Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario (EBS) - Seeking Alpha
Emergent BioSolutions Grants CFO Stock for Contributions - TipRanks
Marshall Wace LLP Has $3.70 Million Stake in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat
Emergent BioSolutions secures $100 million credit facility By Investing.com - Investing.com South Africa
What's Going On With Emergent BioSolutions Stock Wednesday? - Benzinga
Emergent BioSolutions Closes $100 Million Financing - citybiz
Emergent Biosolutions Secures Loan, Bolsters Growth Strategy - TipRanks
Emergent BioSolutions secures $100 million credit facility - Investing.com
Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility - The Manila Times
Emergent BioSolutions Inc. Announces Closing of $100 Million Asset-Backed Loan Facility - Marketscreener.com
Rhumbline Advisers Sells 69,920 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat
Emergent Bio gains after U.S. govt. order for smallpox therapy - MSN
Reviewing Pulmatrix (NASDAQ:PULM) & Emergent BioSolutions (NYSE:EBS) - Defense World
Emergent Biosolutions lays off 300 people - MSN
U.S. secures additional smallpox treatments for $67.4 million - Investing.com
Emergent Bio stock gains after U.S. govt. order (NYSE:EBS) - Seeking Alpha
Emergent BioSolutions Shares Rise on U.S. Smallpox-Treatment Order - MarketWatch
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts - The Manila Times
Emergent confirms ~$400 million in orders for smallpox and mpox vaccines - The Pharma Letter
Emergent Sinks on New Orders for Smallpox, Mpox Vaccine - Baystreet.ca
Emergent Bio gains after confirming $400M orders for 2024/25 - MSN
Emergent BioSolutions secures $400M in vaccine orders - Investing.com India
0.88%
0.42%
자본화:
|
볼륨(24시간):